Teva Pharmaceuticals

New Jersey, United States – The Global Artificial Intelligence In Cyber Security market is projected to experience significant growth, as per the latest research report by Verified Market Research titled “Global Artificial Intelligence In Cyber Security Market Insights, Forecast to 2030.” The report presents a unique perspective on the global market. Analysts anticipate that changing consumption…

New Jersey, United States – The Global AI In Asset Management market is projected to experience significant growth, as per the latest research report by Verified Market Research titled “Global AI In Asset Management Market Insights, Forecast to 2030.” The report presents a unique perspective on the global market. Analysts anticipate that changing consumption patterns will…

New Jersey, United States – Verified Market Research recently released a research report titled “Global Neuromorphic Computing, Ai Hardware And Edge Analytic Market Insight, Forecast.” The report extensively discusses the Global Neuromorphic Computing, Ai Hardware And Edge Analytic market, offering readers a comprehensive understanding of key trends, top strategies, and potential growth opportunities. It incorporates Porter’s…

Yodaplus, a Mumbai-based IT services firm, is leveraging artificial intelligence (AI) to catalyze industry transformations. By integrating AI into its services, Yodaplus is streamlining business operations and enhancing decision-making capabilities for organizations across various sectors. AI is revolutionizing business operations globally by powering automation, analytics, and user experiences. Yodaplus recognizes the importance of embracing…

36Kr Holdings Inc. has announced the launch of its 36Kr Media Lab in Silicon Valley. The lab will focus on embracing the revolution of large language models (LLM) in the content creation industry and optimizing the application of artificial intelligence (AI) for the new economy sector. The lab’s first project, called “Empty Office,” aims…

The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is expected to be around ~USD 150 billion. In 2021, five out of the top 10 selling drugs were mAbs and this trend is forecasted to remain the same over the next five years. Naturally, the pharma industry has seen an…

Teva Pharmaceutical Industries (NYSE:TEVA - Get Free Report) will be releasing its earnings data before the market opens on Wednesday, August 2nd. Analysts expect Teva Pharmaceutical Industries to post earnings of $0.52 per share for the quarter. Parties that are interested in registering for the company's conference call can do so using this link. …

Through an Israeli innovation lab, four big pharma companies are fostering AI-driven start-ups to help solve industry problems.

Nobel Prize-winning chemist Prof. Roger D. Kornberg of Stanford University is joining the advisory board of Rehovot-based Tissue Dynamics, a disruptive artificial intelligence/machine learning (AI/ML) biopharma company. Tissue Dynamics aims to revolutionize drug development using its proprietary robotic DynamiX platform. The sensor-embedded human-on-chip models of organs reduce R&D time, expense, and use of lab animals…

Welcome to FDA Regulatory News and Trends, designed to help you identify significant legal developments and navigate the evolving business, legal and regulatory world. Updated FAQ on medical device shortages to reflect the end of the COVID-19 public health emergency. On May 12, 2023, FDA/CDRH updated its Supply and Shortages of Medical Devices: Frequently…

Michael Bayewitch, PhD Dr. Bayewitch has more than 22 years of experience in the pharmaceutical industry, including in due diligence and in/out-licensing transactions, focusing on oncology, autoimmune diseases, and respiratory diseases. Abu Dhabi, May 15, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has appointed Michael Bayewitch, PhD,…

Michael Bayewitch, PhD Dr. Bayewitch has more than 22 years of experience in the pharmaceutical industry, including in due diligence and in/out-licensing transactions, focusing on oncology, autoimmune diseases, and respiratory diseases. New York, May 15, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has appointed Michael Bayewitch, PhD,…